HSP90AB1 and cancer: In support of this notion, we supply the first evidence that HSP90 N‐terminal inhibitors, but not HSP90 C‐terminal inhibitors and TOP2 inhibitors, destabilized MORC2 in multiple cancer cell lines (Figures 1 and 2 and Figures S1–S6).